Pre-operative chemotherapy for colorectal cancer liver metastases: an update of recent clinical trials G. NastiA. OttaianoR. V. Iaffaioli Mini Review 24 March 2010 Pages: 209 - 218
Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase Andrea RétiÉva PapBarna Budai Original Article 15 October 2009 Pages: 219 - 227
Survival benefit from ovarian metastatectomy in colorectal cancer patients with ovarian metastasis: a retrospective analysis Su Jin LeeJeeyun LeeYoung Suk Park Original Article 10 October 2009 Pages: 229 - 235
Relationship of mRNA expressions of RanBP2 and topoisomerase II isoforms to cytotoxicity of amrubicin in human lung cancer cell lines Yoshitsugu HorioHirotaka OsadaYoshitaka Sekido Original Article 07 October 2009 Pages: 237 - 243
Preclinical pharmacokinetic/pharmacodynamic models to predict synergistic effects of co-administered anti-cancer agents Kosalaram GotetiC. Edwin GarnerPatrick J. Brassil Original Article 16 October 2009 Pages: 245 - 254
Synergistic activity of nilotinib and established chemotherapeutic drugs in imatinib-sensitive and -resistant BCR-ABL-positive cells Aleksandar RadujkovicStefan FruehaufJulian Topaly Original Article 28 October 2009 Pages: 255 - 264
Cisplatin administration following carboplatin desensitization failure in primary peritoneal cancer: a brief report Daniel P. GreeneJames Stuart FerrissAmir A. Jazaeri Original Article 21 October 2009 Pages: 265 - 267
Preclinical study of prolonged administration of trastuzumab as combination therapy after disease progression during trastuzumab monotherapy Kaori Fujimoto-OuchiFumiko SekiguchiKazushige Mori Original Article 11 November 2009 Pages: 269 - 276
Darbufelone, a novel anti-inflammatory drug, induces growth inhibition of lung cancer cells both in vitro and in vivo Xiaolei YeWu ZhouYisheng Lai Original Article 30 March 2010 Pages: 277 - 285
A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer Steven J. CohenMark M. ZalupskiEvan M. Hersh Original Article 24 October 2009 Pages: 287 - 294
Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer Trine Zeeberg Buch-HansenLise BentzenLisa Sengeloev Original Article 31 October 2009 Pages: 295 - 301
Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in rats Karol L. ThompsonBarry A. RosenzweigEugene H. Herman Original Article 14 November 2009 Pages: 303 - 314
Glutamine regulation of doxorubicin accumulation in hearts versus tumors in experimental rats Valentina K. TodorovaYihong KaufmannV. Suzanne Klimberg Original Article 08 November 2009 Pages: 315 - 323
The anti-cancer peptide, PNC-27, induces tumor cell lysis as the intact peptide Kelley A. SookrajWilbur B. BowneMatthew R. Pincus Original Article 25 February 2010 Pages: 325 - 331
Can the 2-13C-uracil breath test be used to predict the effect of the antitumor drug S-1? Yukimoto IshiiShigeru SuzukiSatoshi Asai Original Article 18 November 2009 Pages: 333 - 343
A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment Christopher J. SweeneyChris TakimotoScot C. Remick Original Article 13 November 2009 Pages: 345 - 356
Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis Brett E. HoukCarlo L. BelloRobert J. Motzer Original Article 05 December 2009 Pages: 357 - 371
Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer Sun Jin SymMin-Hee RyuYoon-Koo Kang Original Article 21 November 2009 Pages: 373 - 380
Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors Yun Jung ChoiJin Kyung RhoJae Cheol Lee Original Article 18 November 2009 Pages: 381 - 388
Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumors F. CaponigroD. LorussoS. Comis Original Article 22 November 2009 Pages: 389 - 394
Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer Emmanuel MitryPascal HammelEric Raymond Clinical Trial Report 04 April 2010 Pages: 395 - 403
Do 5-fluorouracil therapies alter CYP2C19 metaboliser status? N. A. HelsbyW. Y. LoG. R. Laking Short Communication 17 February 2010 Pages: 405 - 407
Spontaneous bilateral pneumothorax in metastatic renal cell carcinoma on sunitinib therapy Anilkumar KattaMark J. FeslerJohn M. Richart Short Communication 05 March 2010 Pages: 409 - 412